今天是:   返回主页   |   加入收藏   |   联系我们
引用本文:
【打印本页】   【HTML】   【下载PDF全文】   查看/发表评论  下载PDF阅读器  关闭
附件
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 1674次   下载 1119 本文二维码信息
码上扫一扫!
分享到: 微信 更多
中国式森田疗法联合前列安栓治疗ⅢA型前列腺炎临床疗效观察
刘步平1, 梁启放2, 张善禹2, 林亮3, 梁沛华3
1.广州中医药大学经济与管理学院, 广州 510006;2.广州中医药大学针灸康复临床医学院, 广州 510006;3.广州中医药大学校长办公室, 广州 510006
摘要:
[目的]探讨中国式森田疗法联合前列安栓治疗ⅢA型前列腺炎的临床效果。[方法]将符合标准的121例ⅢA型前列腺炎患者随机分成中国式森田疗法组(治疗组)60例和单纯前列安栓组(对照组)61例,分别给予中国式森田疗法联合前列按栓和单纯前列安栓治疗12周,治疗前后用美国国立卫生院慢性前列腺炎症状积分指数(NIH-CPSI)评定疗效。[结果]治疗后,治疗组治愈率为28.33%,总有效率为86.67%;对照组治愈率为27.87%,总有效率为68.85%,治愈率组间差异无统计学意义(P>0.05),总有效率差异有统计学意义(P<0.05);NIH-CPSI评定,两组疼痛/不适、排尿、生活质量的评分及总分均较治疗前明显减少(P<0.01),且治疗组疼痛/不适、生活质量的评分和总分的减少均比对照组明显(P<0.01),两组治疗后的排尿评分差异无统计学意义(P>0.05)。[结论]联合中国式森田疗法比单纯前列安栓治疗ⅢA型前列腺炎能明显改善疼痛/不适症状,提高生活质量和总有效率。
关键词:  ⅢA型前列腺炎  心理治疗  中国式森田疗法  前列安栓  美国国立卫生院慢性前列腺炎症状积分指数(NIH-CPSI)  疗效
DOI:10.11656/j.issn.1672-1519.2019.04.12
分类号:R697.33
基金项目:广东省科技计划项目(2010B031600268)。
Efficacy of Chinese Morita therapy combined with Qianliean Shuan suppository on patients with ⅢA prostatitis
LIU Buping1, LIANG Qifang2, ZHANG Shanyu2, LIN Liang3, LIANG Peihua3
1.School of Economic and Management, Guangzhou University of Chinese Medicine, Guangzhou 510006, China;2.Clinical medical College of Acupuncture and Moxibustion Rehabilitation, Guangzhou University of Chinese Medicine, Guangzhou 510006, China;3.Principal's Office, Guangzhou University of Chinese Medicine, Guangzhou 510006, China
Abstract:
[Objective] To explore the effect of Chinese Morita therapy combined with Qianliean Shuan suppository in patients with ⅢA prostatitis.[Methods] The 121 patients with standard ⅢA prostatitis were randomly divided into 60 cases of Chinese type Morita therapy group (group A) and 61 cases (group B) of Qianliean Shuan suppository group (group B). They were given the Chinese Morita therapy combined with the Qianliean Shuan suppository and the simple Qianliean Shuan suppository for 8 weeks respectively. Before and after the treatment,the National Institutes of Health Chronic Prostatitis Symptom Score (NIH-CPSI) were evaluated.[Results] The cure rate and total effective rate of the group A were 28.33% and 86.67%,while that were 27.87% and 68.85% of the group B. The cure rate between the groups was not significant (P>0.05),while the total effective rate between the groups was significant (P<0.05).The total score and the scores of pain/discomfort,urination,quality of life in group A and group B by NIH-CPSI were significantly decreased (P<0.01). The total score and the scores of pain/discomfort,quality of life by NIH-CPSI were significantly decreased in group A than that in group B (P< 0.05),while the score of urination after treatment in two groups were not significantly different (P>0.05).[Conclusion] Chinese Morita therapy combined with Qianliean Shuan suppository can reduce pain/discomfort and improve the quality of life and total effective rate in patients with ⅢA prostatitis.
Key words:  ⅢA prostatitis  psychotherapy  Chinese Morita therapy  Qianliean Shuan suppository  the National Institutes of Health Chronic Prostatitis Symptom Score (NIH-CPSI)  curative effect
关注公众号二维码